High-intensity Exercise After Treatment (HEAT)

University of Nebraska logo

University of Nebraska

Status

Terminated

Conditions

Breast Cancer
Breast Neoplasm Female

Treatments

Behavioral: High-Intensity Interval Training
Behavioral: Moderate-Intensity Exercise

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT04950010
1U54GM115458 (U.S. NIH Grant/Contract)
0439-21-FB

Details and patient eligibility

About

This pilot study tests the feasibility and preliminary efficacy of an 8-week, 3-arm pilot exercise trial in which 45 breast cancer survivors will be randomized to high-intensity interval training (HIIT; n=15), moderate-intensity aerobic training (MOD; n=15), or Usual Care (UC; n=15).

Full description

Aim 1: Determine the feasibility and acceptability of an 8-week high-intensity interval training (HIIT) program compared with a standard moderate-intensity aerobic training (MOD) program in 45 breast cancer survivors prescribed aromatase inhibitors. Aim 2: Calculate effect sizes associated with the 8-week HIIT program, compared with MOD and Usual Care (UC), on cognitive and cardiovascular functions in 45 breast cancer survivors. Eligible individuals will be women diagnosed with Stages I-IIIa breast cancer, have completed primary treatment (i.e., surgery, chemotherapy, and/or radiation therapy), and currently prescribed an aromatase inhibitor. The specific aims are: 1) Determine the feasibility and acceptability of an 8-week high-intensity interval training (HIIT) program compared with a standard moderate-intensity (MOD) program; and 2) Calculate effect sizes associated with the 8-week HIIT program, compared with MOD and usual care (UC), on cognitive and cardiovascular functions. Cognitive function is operationalized as performance on executive function and working memory tasks. Cardiovascular function is operationalized as exercise capacity (VO2peak, heart rate recovery), resting function (heart rate, blood pressure), and cardiovascular structure/function (arterial stiffness, arterial wall thickness, endothelial function). Associations between change in cardiovascular outcomes and change in cognitive outcomes across the intervention period will also be explored.

Enrollment

7 patients

Sex

Female

Ages

19+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult female (aged 19 or older)
  • First, primary diagnosis of Stage I-IIIa breast cancer
  • Hormone receptor positive (ER+ and/or PR+) diagnosis
  • Human epidermal growth factor receptor 2 negative (HER2-) diagnosis
  • Completed primary adjuvant treatment (i.e., surgery, chemotherapy, and/or radiation therapy)
  • Currently prescribed an aromatase inhibitor
  • No evidence of possible cognitive impairment as assessed using the Telephone Interview of Cognitive Status (TICS-M; score >21)
  • Sedentary except for casual lifestyle recreation. This is defined as self-reporting 20+ minutes of exercise physical activity on 2 or fewer days per week within the previous six months.
  • Receive physician's clearance to participate in an exercise program
  • Agree to be randomized
  • Fully vaccinated for COVID-19 ≥2 weeks prior to participation
  • Provide written informed consent to participate in study

Exclusion criteria

  • Males.
  • Stage 0 breast cancer diagnosis or metastatic disease
  • Currently receiving chemotherapy or radiation therapy for any cancer
  • Scheduled to receive breast surgery (e.g., mastectomy, reconstructive surgery) during the study period
  • Second cancer diagnosis (excluding non-invasive skin cancers; including breast cancer recurrence)
  • Self-report an 20+ minutes of exercise physical activity on 3+ days per week for the previous 6 months
  • Pregnant or plan to become pregnant during study period.
  • Is not cleared to participate in exercise by a physician.
  • Enrolled in another physical activity program
  • Unable to cycle on a stationary bike
  • Unwilling to complete study requirements
  • History of stroke, transient ischemic attack, other neurological disorders, or brain surgery involving tissue removal
  • Clinically significant TICS-M score (<21) during baseline procedures
  • Not fully vaccinated for COVID-19

Trial design

7 participants in 3 patient groups

High-Intensity Interval Training (HIIT)
Experimental group
Description:
Breast cancer survivors randomized to HIIT will participate in a high-intensity interval training program for 8 weeks.
Treatment:
Behavioral: High-Intensity Interval Training
Moderate-Intensity Exercise (MOD)
Active Comparator group
Description:
Breast cancer survivors randomized to MOD will participate in a moderate-intensity aerobic exercise program for 8 weeks.
Treatment:
Behavioral: Moderate-Intensity Exercise
Usual Care (UC)
No Intervention group
Description:
Individuals randomized to UC will be instructed to continue standard cancer care and engage in habitual lifestyle behaviors.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems